Reader Response: Risk of Hospitalization and Death Associated With Pimavanserin Use in Older Adults With Parkinson Disease

Hwang et al.1 recently published a retrospective analysis of the risk of hospitalization or mortality in patients with Parkinson disease (PD) using pimavanserin in long-term care facilities. However, the study design and cohort selection do not support the authors’ conclusions.

Read article at journal's website

Related Articles

Responses

Your email address will not be published. Required fields are marked *